Journals / Journal of the Turkish-German Gynecological Association / 2005 / Cilt: 6 - Sayı: 4

Gebelerde ve gebe olmayan kadınlarda tuba uterina leukemia inhibitory faktör düzeylerinin karşılaştırılması: Bir ön çalışma raporu

Comparison of tuba uterina leukemia inhibitory factor levels in pregnant and non-pregnant women: A preliminary report

Pages
269–271
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is possible that there may be an increase in endometrial LIF production during implantation while the tubal secretion decreases and it may be concluded that paracrine factors are more effective than endocrine factors in the regulation of secretion of LIF.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to compare the levels of leukemia inhibitory factor (LIF) in isthmic tubal tissue of pregnant and non-pregnant women.
📊
Key Findings & Data:Because of the effects of LIF on successful fertilization and early embryonic development, we postulated that there should be increased LIF concentration in pregnant tubal specimens.
💡
Conclusion & Impact:It is possible that there may be an increase in endometrial LIF production during implantation while the tubal secretion decreases and it may be concluded that paracrine factors are more effective than endocrine factors in the regulation of secretion of LIF.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to compare the levels of leukemia inhibitory factor (LIF) in isthmic tubal tissue of pregnant and non-pregnant women. Because of the effects of LIF on successful fertilization and early embryonic development, we postulated that there should be increased LIF concentration in pregnant tubal specimens. Materials and Methods: Isthmic tubal tissues from 20 women who desire tubal ligation were obtained by mini laparotomy. Study participants were divided into the following 2 distinct groups: (1) normal pregnant women who desire dilatation and currettage and tubal ligation (n=10), (2) non-pregnant women who desire tubal ligation only (n=10). LIF levels were detected in the homogenized fluid by an enzyme-linked immunosorbant assay (ELISA). Results: There was no significant difference in tubal tissue LIF levels between the groups. Conclusion: Our study has shown that tubal LIF secretion was normal during early weeks of pregnancy. It is possible that there may be an increase in endometrial LIF production during implantation while the tubal secretion decreases and it may be concluded that paracrine factors are more effective than endocrine factors in the regulation of secretion of LIF.

Özet

Amaç: Bu çalışmanın amacı, gebe ve gebe olmayan kadınlarda istmik tubal dokuda leukemia inhibitory factor (LIF) düzeylerini karşılaştırmaktı. LIF’in başarılı fertilizasyon ve erken embryonik gelişim üzerindeki etkilerinden dolayı, gebelerden elde edilen tuba örneklerinde LIF konsantrasyonlarının daha yüksek olacağı düşünüldü. Materyal ve Metot: İstmik tubal dokular, tüp ligasyonu isteyen 20 kadından mini-laparotomi ile elde edildi. Hastalar iki gruba ayrıldı: (1) dilatasyon küretajla birlikte tüp ligasyonu talebi olan normal gebe kadınlar (n=10), (2) tüp ligasyonu isteyen gebe olmayan kadınlar (n=10). LIF düzeyleri homojenize sıvıda ELISA yöntemi ile saptandı. Sonuçlar: Gruplar arasında tubal doku LIF düzeyleri açısından anlamlı fark saptanmadı.ında tubal LIF sekresyonunun normal olduğunu göstermektedir. implantasyon döneminde endometriyal LIF üretimi artarken tubal dokuda sekresyonun azalması söz konusu olabilir ve LIF sekresyonunun düzenlenmesinde parakrin faktörlerin endokrin faktörlerden daha etkili olduğu söylenebilir.

🔖

Cite This Article

KILINÇ, M., KIRAN, G., VARDAR, M. A., ERTOPÇU, K., GÜVEN, A. M., KIRAN, H. (2022). Gebelerde ve gebe olmayan kadınlarda tuba uterina leukemia inhibitory faktör düzeylerinin karşılaştırılması: Bir ön çalışma raporu. Journal of the Turkish-German Gynecological Association, Cilt: 6 - Sayı: 4, 269–271. https://ajindex.com/articles/568048

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Arici A, Engin O, Attar E, Olive DL. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab 1995;80(6):1908-15
  2. Salamonsen LA, Nie G, Dimitriadis E, Robb L, Findlay JK. Genes involved in implantation. Reprod Fertil Dev 2001;13(1):41-9
  3. Kuşcu NK, Koyuncu FM, Var A, Lacin S, Uyanık BS, Ceylan E. Clomiphene citrate does not adversely affect endometrial leukemia inhibitory factor levels. Gynecol Endocrinol 2002;16(2):151-4
  4. Metcalf D. Leukemia inhibitory factor-a puzzling polyfunctional regulator. Growth Factors 1992;7(3):169-73
  5. Fry RC. The effect of leukaemia inhibitory factor (LIF) on embryogenesis. Reprod Fertil Dev 1992;4(4):449-58 6. Hambartsoumian E. Human endometrial leukemia inhibitor factor (LIF) secretion and its relationship to sonographic endometrial appearance. Am J Reprod Immunol 1997;37(4):320-5 7. Keltz MD, Attar E, Buradagunta S, Olive DL, Kliman HJ, Arici A. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in the human fallopian tube. Am J Obstet Gynecol 1996;175(6):1611-9
  6. Palter SF, Mulayim N, Senturk L, Arici A. Interleukin-8 in the human fallopian tube. J Clin Endocrinol Metab 2001;86(6):2660-7
  7. Mulayim N, Palter SF, Selam B, Arici A. Expression and regulation of interleukin-8 in human fallopian tubal cells. Am J Obstet Gynecol 2003 Mar;188(3):651-6
  8. Metcalf D. The leukemia inhibitory factor (LIF). Int J Cell Cloning 1991 Mar;9(2):95-108
  9. Vogiagis D, Salamonsen LA. Review: The role of leukaemia inhibitory factor in the establishment of pregnancy. J Endocrinol 1999 Feb;160(2):181-90
  10. Lavranos TC, Rathjen PD, Seamark RF. Trophic effects of myeloid leukaemia inhibitory factor (LIF) on mouse embryos. J Reprod Fertil 1995 Nov;105(2): 331-8
  11. Kojima K, Kanzaki H, Iwai M, Hatayama H, Fujimoto M, Inoue T, Horie K, Nakayama H, Fujita J, Mori T. Expression of leukemia inhibitory factor in human endometrium and placenta. Biol Reprod 1994 Apr;50(4):882-7
  12. Senturk LM, Arici A. Leukemia inhibitory factor in human reproduction. Am J Reprod Immunol 1998 Feb;39(2):144-51
  13. Chen DB, Hilsenrath R, Yang ZM, Le SP, Kim SR, Chuong CJ, Poindexter AN 3rd, Harper MJ. Leukaemia inhibitory factor in human endometrium during the menstrual cycle: cellular origin and action on production of glandular epithelial cell prostaglandin in vitro. Hum Reprod 1995 Apr;10(4):911-8
  14. Attar E, Ozsait B, Bulgurcuoglu S, Serdaroglu